Our Business Models

The KOA SHOJI HOLDINGS Group
is a pharmaceutical group consisting of a trading company
that imports APIs and a maker that manufactures
and sells generic drugs.

Holdings Group structure

By providing high-quality and inexpensive imported APIs for manufacturing, selling, and contract manufacturing of pharmaceuticals,
we are developing businesses that can meet the diverse needs of the pharmaceutical industry, particularly for generic drugs, under a system that enables integrated manufacturing from APIs to pharmaceuticals.

Consistent manufacturing from drug substance to formulation

Our Features

API Sales Business

Our pharmaceutical analysis center is equipped with specialized analysis equipment, enabling the analysis of imported APIs in-house to ensure quality promptly.
We have trustworthy relationships with overseas suppliers and the research capability to select suppliers with a wealth of information from starting materials. Our quality assurance department has extensive experience in pharmaceutical affairs, and we can provide detailed support for approval and post-application follow-up to manufacturers.
We are equipped with knowledge and facilities to provide a wide range of follow-up services to help customers comply with the Pharmaceutical Affairs Law.

API sales business

※See the virtual tour for details.

Manufacture and Sale of Pharmaceuticals Business

Our system enables us to conduct the entire process from development to manufacturing. Additionally, our production facilities enable us to manufacture a wide variety of highly pharmacologically active injectable drugs in small quantities, requiring advanced technology and investments. These facilities also make it possible to undertake contract development and manufacturing in the original field.

※See the virtual tour for details.

RELATED PAGES


TOP
TOP